SIRO Clinpharm, a global contract research organization with base in India, US, Europe and Israel, announced the opening of its office in Prague, Czech Republic.

"Czech Republic has an excellent resource base of GCP trained, well qualified clinical research personnel," said Scott Spector, president, Strategic Operations, Europe. "Our new office in Czech Republic will further strengthen our operational capabilities in Europe," he added.

Dr Ladislav Pecen, country manager will be in charge of operations in Czech Republic for SIRO. To begin with SIRO will roll out clinical monitoring, biostatistics and statistical programming services from the new office. From its offices in Offenbach, Germany and Mumbai, India SIRO has been offering these and other services like Clinical Data Management, Quality Assurance and Medical Writing, Medical Affairs & Pharmacovigilance for more than a decade.

"We established our presence in Europe with the acquisition of Omega Mediation, a Germany based CRO in April 2008. During the last 18 months, as a part of our global strategy, we have expanded our capabilities by opening offices in North East and South East Europe. Our Czech Republic office will consolidate our position in Central Europe." said Dr Chetan Tamhankar, chief operating officer of SIRO Clinpharm. "We will definitely not stop here and have already started eyeing other countries in Western Europe for further expansion," he added. SIRO has a rich experience servicing top global pharma and biotech firms since its inception in 1996 in India.

SIRO Clinpharm Private Limited (SIRO) is among one of the leading global Clinical Research Organizations, offering full scope services, conducting clinical trials in the pharmaceutical, biotechnology and medical devices sectors in compliance with International Standards.